RhumbLine Advisers’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.4M Buy
95,142
+8,412
+10% +$1.28M 0.01% 890
2025
Q1
$13.1M Buy
86,730
+3,405
+4% +$513K 0.01% 902
2024
Q4
$15.4M Sell
83,325
-3,009
-3% -$555K 0.01% 838
2024
Q3
$17M Sell
86,334
-1,952
-2% -$384K 0.02% 794
2024
Q2
$18.2M Buy
88,286
+1,245
+1% +$257K 0.02% 721
2024
Q1
$23.6M Sell
87,041
-81
-0.1% -$21.9K 0.02% 612
2023
Q4
$20.6M Buy
87,122
+1,875
+2% +$443K 0.02% 671
2023
Q3
$16.7M Sell
85,247
-133
-0.2% -$26.1K 0.02% 722
2023
Q2
$18M Sell
85,380
-7,489
-8% -$1.57M 0.02% 707
2023
Q1
$18.7M Buy
92,869
+6,833
+8% +$1.38M 0.02% 638
2022
Q4
$18.7M Buy
86,036
+2,715
+3% +$592K 0.03% 617
2022
Q3
$16.4M Buy
83,321
+624
+0.8% +$123K 0.02% 623
2022
Q2
$17.7M Buy
82,697
+9,214
+13% +$1.97M 0.03% 603
2022
Q1
$20.9M Sell
73,483
-12,085
-14% -$3.43M 0.03% 555
2021
Q4
$32.2M Buy
85,568
+4,337
+5% +$1.63M 0.04% 403
2021
Q3
$33.5M Sell
81,231
-3,468
-4% -$1.43M 0.05% 364
2021
Q2
$31.3M Sell
84,699
-50,319
-37% -$18.6M 0.04% 400
2021
Q1
$39.1M Sell
135,018
-2,843
-2% -$824K 0.05% 309
2020
Q4
$34.4M Sell
137,861
-4,179
-3% -$1.04M 0.05% 346
2020
Q3
$32.2M Sell
142,040
-5,138
-3% -$1.16M 0.05% 327
2020
Q2
$25.7M Buy
147,178
+12,432
+9% +$2.17M 0.04% 382
2020
Q1
$17M Sell
134,746
-3,261
-2% -$412K 0.04% 437
2019
Q4
$21.1M Buy
138,007
+3,104
+2% +$474K 0.04% 466
2019
Q3
$17.9M Sell
134,903
-1,486
-1% -$197K 0.03% 489
2019
Q2
$19.4M Buy
136,389
+1,465
+1% +$208K 0.04% 461
2019
Q1
$19.6M Sell
134,924
-1,795
-1% -$261K 0.04% 442
2018
Q4
$15.5M Buy
136,719
+33,334
+32% +$3.77M 0.03% 520
2018
Q3
$13.9M Sell
103,385
-3,578
-3% -$481K 0.03% 549
2018
Q2
$12M Buy
106,963
+4,842
+5% +$544K 0.02% 597
2018
Q1
$10.9M Sell
102,121
-5,892
-5% -$629K 0.02% 634
2017
Q4
$11.8M Buy
108,013
+3,201
+3% +$350K 0.02% 612
2017
Q3
$11.3M Buy
104,812
+5,574
+6% +$602K 0.02% 614
2017
Q2
$10M Sell
99,238
-423
-0.4% -$42.8K 0.02% 634
2017
Q1
$8.97M Buy
99,661
+3,150
+3% +$283K 0.02% 697
2016
Q4
$7.35M Buy
96,511
+4,957
+5% +$378K 0.02% 761
2016
Q3
$7.63M Buy
91,554
+2,104
+2% +$175K 0.02% 679
2016
Q2
$7.37M Buy
89,450
+2,689
+3% +$222K 0.02% 657
2016
Q1
$6.59M Buy
86,761
+116
+0.1% +$8.81K 0.02% 706
2015
Q4
$6.97M Buy
86,645
+477
+0.6% +$38.3K 0.02% 667
2015
Q3
$5.47M Buy
86,168
+3,442
+4% +$219K 0.02% 766
2015
Q2
$5.82M Buy
82,726
+2,091
+3% +$147K 0.02% 761
2015
Q1
$6.39M Buy
80,635
+4,820
+6% +$382K 0.02% 716
2014
Q4
$4.83M Buy
75,815
+745
+1% +$47.4K 0.01% 819
2014
Q3
$4.49M Buy
75,070
+977
+1% +$58.4K 0.01% 827
2014
Q2
$3.97M Sell
74,093
-6,774
-8% -$363K 0.01% 923
2014
Q1
$4.88M Sell
80,867
-139
-0.2% -$8.39K 0.01% 832
2013
Q4
$4.3M Sell
81,006
-4,793
-6% -$254K 0.01% 903
2013
Q3
$3.97M Buy
85,799
+590
+0.7% +$27.3K 0.01% 925
2013
Q2
$3.5M Buy
+85,209
New +$3.5M 0.01% 963